Global Medical Marijuana Market to 2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,950	179 Pages	QualiKet Research	February, 2022	QUA17148938

Best Price Guarantee
Price	from $3,950
Length	179 Pages
Publisher	QualiKet Research
Published Date	February, 2022
SKU	QUA17148938

Global Medical Marijuana Market to 2027

Global Medical Marijuana Market to 2027

Market Overview

Marijuana is a chemical plant which contains cannabis as a medical property. It is used as raw material by various pharmaceutical companies to manufacture drugs for different therapeutic applications. Marijuana extract is used to treat various diseases including Alzheimer’s disease, Migraine, Arthritis, Chronic Pain, and Others.

Market Drivers

Increase in awareness regarding various medical applications such as appetite enhancement, pain management, and reducing eye pressure is the key driving factor which is expected to boost the global medical marijuana market growth. Furthermore, increase in number of legalizing the use of medical marijuana in various parts across the globe will have the positive impact on market growth. Moreover, rise in mergers and acquisitions in the medical cannabis industry will fuel the market growth.

Market Restraints

However, Medical marijuana is not approved by USFDA (Food and Drug Administration) for the treatment of cancer which is major restraining factor which is expected to hamper the global medical marijuana market growth.

Market Segmentation

Global Medical Marijuana Market is segmented into route of administration such as Oral, Inhalation, and Topical. Further, market is segmented into application such as Alzheimer’s disease, Migraine, Arthritis, Chronic Pain, and Others.

Also, Global Medical Marijuana Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as GW Pharmaceuticals PLC, The Peace Naturals Project, Insys Therapeutics, Inc., Cannabis Sativa, INC., Green Relief Inc., Medical Marijuana, Inc., Aurora Cannabis Inc, Aphria Incorporation, MedReleaf Corporation,and Canopy Growth Corporation.

Market Taxonomy

By Route of Administration

Oral
Inhalation
Topical

By Application

Alzheimer’s disease
Migraine
Arthritis
Chronic Pain
Others

By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

1 Introduction: 1.1 Objective of the Study; 1.2 Market definition; 1.3 Market Scope
2 Research Methodology: 2.1 Data Mining; 2.2 Validation; 2.3 Primary Interviews; 2.4 List of Data Sources
3 Executive Summary
4 Global Medical Marijuana Market Outlook: 4.1 Overview; 4.2 Market Dynamics; 4.2.1 Drivers; 4.2.2 Restraints; 4.2.3 Opportunities; 4.3 Porters Five Force Model; 4.4 Value Chain Analysis
5 Global Medical Marijuana Market, By Route of Administration: 5.1 Y-o-Y Growth Comparison, By Route of Administration; 5.2 Global Medical Marijuana Market Share Analysis, By Route of Administration; 5.3 Global Medical Marijuana Market Size and Forecast, By Route of Administration; 5.3.1 Oral; 5.3.2 Inhalation; 5.3.3 Topical
6 Global Medical Marijuana Market, By Application: 6.1 Y-o-Y Growth Comparison, By Application; 6.2 Global Medical Marijuana Market Share Analysis, By Application; 6.3 Global Medical Marijuana Market Size and Forecast, By Application; 6.3.1 Alzheimer’s Diseases; 6.3.2 Migraine; 6.3.3 Arthritis; 6.3.4 Chronic Pain; 6.3.5 Others
7 Global Medical Marijuana Market, By Region: 7.1 Global Medical Marijuana Market Share Analysis, By Region; 7.2 Global Medical Marijuana Market Share Analysis, By Region; 7.3 Global Medical Marijuana Market Size and Forecast, By Region
8 North America Medical Marijuana Market Analysis and Forecast (2017 – 2027): 8.1 Introduction; 8.2 North America Medical Marijuana Market Share Analysis, By Route of Administration; 8.3 North America Medical Marijuana Market Size and Forecast, By Application; 8.4 North America Medical Marijuana Market Size and Forecast, By Country; 8.4.1 U.S; 8.4.2 Canada; 8.4.3 Mexico
9 Europe Medical Marijuana Market Analysis and Forecast (2017 – 2027): 9.1 Introduction; 9.2 Europe Medical Marijuana Market Share Analysis, By Route of Administration; 9.3 Europe Medical Marijuana Market Size and Forecast, By Application; 9.4 Europe Medical Marijuana Market Size and Forecast, By Country; 9.4.1 Germany; 9.4.2 France; 9.4.3 UK; 9.4.4. Rest of Europe
10 Asia Pacific Medical Marijuana Market Analysis and Forecast (2017 – 2027): 10.1 Introduction; 10.2 Asia Pacific Medical Marijuana Market Share Analysis, By Route of Administration; 10.3 Asia Pacific Medical Marijuana Market Size and Forecast, By Application; 10.4 Asia Pacific Medical Marijuana Market Size and Forecast, By Country; 10.4.1 China; 10.4.2 Japan; 10.4.3 India; 10.4.4. Rest of Asia Pacific
11 Latin America Medical Marijuana Market Analysis and Forecast (2017 – 2027): 11.1 Introduction; 11.2 Latin America Medical Marijuana Market Share Analysis, By Route of Administration; 11.3 Latin America Medical Marijuana Market Size and Forecast, By Application; 11.4 Latin America Medical Marijuana Market Size and Forecast, By Country
12 Middle East Medical Marijuana Market Analysis and Forecast (2017 – 2027): 12.1 Introduction; 12.2 Middle East Medical Marijuana Market Share Analysis, By Route of Administration; 12.3 Middle East Medical Marijuana Market Size and Forecast, By Application; 12.4 Middle East Medical Marijuana Market Size and Forecast, By Country
13 Competitive Analysis: 13.1 Competition Dashboard; 13.2 Market share Analysis of Top Vendors; 13.3 Key Development Strategies
14 Company Profiles: 15.1 GW Pharmaceuticals PLC; 15.1.1 Overview; 15.1.2 Offerings; 15.1.3 Key Financials; 15.1.4 Business Segment & Geographic Overview; 15.1.5 Key Market Developments; 15.1.6 Key Strategies; 15.2 The Peace Naturals Project; 15.2.1 Overview; 15.2.2 Offerings; 15.2.3 Key Financials; 15.2.4 Business Segment & Geographic Overview; 15.2.5 Key Market Developments; 15.2.6 Key Strategies; 15.3 Insys Therapeutics, Inc; 15.3.1 Overview; 15.3.2 Offerings; 15.3.3 Key Financials; 15.3.4 Business Segment & Geographic Overview; 15.3.5 Key Market Developments; 15.3.6 Key Strategies; 15.4 Cannabis Sativa, INC; 15.4.1 Overview; 15.4.2 Offerings; 15.4.3 Key Financials; 15.4.4 Business Segment & Geographic Overview; 15.4.5 Key Market Developments; 15.4.6 Key Strategies; 15.5 Green Relief Inc; 15.5.1 Overview; 15.5.2 Offerings; 15.5.3 Key Financials; 15.5.4 Business Segment & Geographic Overview; 15.5.5 Key Market Developments; 15.5.6 Key Strategies; 15.6 Medical Marijuana, Inc; 15.6.1 Overview; 15.6.2 Offerings; 15.6.3 Key Financials; 15.6.4 Business Segment & Geographic Overview; 15.6.5 Key Market Developments; 15.6.6 Key Strategies; 15.7 Aurora Cannabis Inc; 15.7.1 Overview; 15.7.2 Offerings; 15.7.3 Key Financials; 15.7.4 Business Segment & Geographic Overview; 15.7.5 Key Market Developments; 15.7.6 Key Strategies; 15.8 Aphria Incorporation; 15.8.1 Overview; 15.8.2 Offerings; 15.8.3 Key Financials; 15.8.4 Business Segment & Geographic Overview; 15.8.5 Key Market Developments; 15.8.6 Key Strategies; 15.9 MedReleaf Corporation; 15.9.1 Overview; 15.9.2 Offerings; 15.9.3 Key Financials; 15.9.4 Business Segment & Geographic Overview; 15.9.5 Key Market Developments; 15.9.6 Key Strategies; 15.10 Canopy Growth Corporation; 15.10.1 Overview; 15.10.2 Offerings; 15.10.3 Key Financials; 15.10.4 Business Segment & Geographic Overview; 15.10.5 Key Market Developments; 15.10.6 Key Strategies